Concepedia

Shikiko Watanabe

SW

12

Publications

657

Citations

12

H-Index

1991

Active since

Affiliations

UCB Pharma (Belgium)(Current)

Structure Fédérative de Recherche en Biologie et Santé de Rennes

University of Birmingham

Shikiko Watanabe is an author at UCB Pharma (Belgium) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1991–2017

12

Publications

12

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study

Rocío Lledó‐García, Shikiko Watanabe, Grant Langdon et al. · Science Translational Medicine · 2017 · 195 citations

Regulation of cell cycle and productivity in NS0 cells by the over‐expression of p21<sup>CIP1</sup>

Shikiko Watanabe, John Shuttleworth, Mohamed Al‐Rubeai · Biotechnology and Bioengineering · 2001 · 76 citations

, , +19

Modulation of Cell Cycle for Enhancement of Antibody Productivity in Perfusion Culture of NS0 Cells

Neysi Ibarra, Shikiko Watanabe, John Shuttleworth et al. · Biotechnology Progress · 2003 · 60 citations

Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor

Keiji Kimura, H Matsubara, S Sogoh et al. · The Journal of Immunology · 1991 · 55 citations

Brivaracetam Single and Multiple Rising Oral Dose Study in Healthy Japanese Participants: Influence of CYP2C19 Genotype

Armel Stockis, Shikiko Watanabe, Elisabeth Rouits et al. · Drug Metabolism and Pharmacokinetics · 2014 · 54 citations

Rows per page

1–5 of 12